Li Li
Founder chez SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
Fortune : 686 M $ au 31/03/2024
Profil
Li Li est un homme d'affaires qui a fondé Shenzhen Hepalink Pharmaceutical Group Co., Ltd. et qui a été à la tête de 5 entreprises différentes. Actuellement, il occupe le poste de président de Shenzhen Techdow Pharmaceutical Co., Ltd. et de président de Shenzhen Hepalink Pharmaceutical Group Co., Ltd., de président-directeur général de Hepalink USA, Inc. et de président de Shenzhen Duopule Industrial Development Co., Ltd. (toutes deux sont des filiales de Shenzhen Hepalink Pharmaceutical Group Co., Ltd.). Il est également membre du conseil d'administration de Cytovance Biologics, Inc. (ancien président), de Shenzhen Leren Technology Co. Ltd. et Urumqi Feilaishi Equity Investment Co. Ltd. M. Li a obtenu un diplôme de premier cycle à l'université du Sichuan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 514 349 899 ( 41,24% ) | 594 M $ | 31/03/2024 | |
HIGHTIDE THERAPEUTICS INC
23,61% | 02/02/2024 | 121 515 210 ( 23,61% ) | 92 M $ | 31/03/2024 |
Postes actifs de Li Li
| Sociétés | Poste | Début |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Founder | 21/04/1998 |
Shenzhen Leren Technology Co. Ltd.
 Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Shenzhen Leren Technology Co. Ltd. is a Chinese company that engages in technology development. | Director/Board Member | - |
| Urumqi Feilaishi Equity Investment Co. Ltd. | Director/Board Member | - |
| Shenzhen Techdow Pharmaceutical Co., Ltd. | Chairman | - |
Hepalink USA, Inc.
 Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Chief Executive Officer | - |
Shenzhen Duopule Industrial Development Co., Ltd.
 Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Chairman | 13/01/2014 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Director/Board Member | - |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Chairman | - |
Anciens postes connus de Li Li
| Sociétés | Poste | Fin |
|---|---|---|
| HIGHTIDE THERAPEUTICS, INC. | Director/Board Member | 02/02/2024 |
Formation de Li Li
| Sichuan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
Shenzhen Leren Technology Co. Ltd.
Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Shenzhen Leren Technology Co. Ltd. is a Chinese company that engages in technology development. | Technology Services |
| Urumqi Feilaishi Equity Investment Co. Ltd. | |
| Shenzhen Techdow Pharmaceutical Co., Ltd. | |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Health Technology |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Distribution Services |
| Hightide Therapeutics, Inc. | |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. |
